Why is BP stock surging amid Shell merger talks?
How will Fannie Mae treat crypto assets in mortgages?
Why is Bumble cutting 30% of its workforce?
What impact will Fed’s capital rule changes have?
How did Zohran Mamdani’s win affect NYC real estate?
Why are Tesla sales dropping in Europe?
How are tariff tensions affecting Fed rate decisions?
Sarepta Therapeutics Is Already Down 84% This Year. And The Other Shoe Just Dropped
investors.com/news/technology/sarepta-stock-elevidys-deaths-fda-investigation
Sarepta stock dropped again Wednesday after the FDA announced it's investigating the deaths of two patients who received Elevidys.
The post Sarepta Therapeutics Is Already Down 84% This Year. And The Other Shoe Just Dropped. appeared first on Investor's Business Daily.
This story appeared on investors.com, 2025-06-25 17:28:39.